Syntel Reports First Quarter 2015 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Syntel Reports First Quarter 2015 Financial Results

Highlights:

  • Q1 revenue of $220.6M, up 1% from year-ago quarter, down 6% sequentially
  • Q1 EPS of $0.48 per diluted share, down 31% from year-ago quarter, and 43% sequentially
  • Q1 cash & short term investments of $867M
  • Global Headcount of 24,534 on March 31, 2015, up 1% versus prior year

TROY, Mich., April 23, 2015 (GLOBE NEWSWIRE) -- Syntel, Inc. (Nasdaq: SYNT ), a global provider of digital transformation, information technology and knowledge process services to Global 2000 companies, today announced financial results for the first quarter, ended March 31, 2015.

First Quarter Financial Highlights

Syntel's revenue for the first quarter increased one percent to $220.6 million from $219.5 million in the prior-year period, and declined six percent from $235.3 million in the fourth quarter of 2014. During the first quarter, Banking and Financial Services accounted for 47.8 percent of total revenue, with Retail, Logistics and Telecom at 17.1 percent, Healthcare and Life Sciences at 15.6 percent, Insurance at 15.6 percent, and Manufacturing at 3.9 percent.

The Company's gross margin was 35.7 percent in the first quarter, compared to 43.7 percent in the prior-year period and 41.4 percent in the fourth quarter of 2014. Selling, General and Administrative (SG&A) expenses were 16 percent of revenue in the first quarter, compared to 14.7 percent in the prior-year period and 10.2 percent in the previous quarter.

The first quarter income from operations was 19.7 percent of revenue as compared to 29.1 percent in the prior-year period and 31.2 percent in the fourth quarter. The sequential decline in operating margin during the first quarter primarily reflects lower revenue and the impact of currency-related balance sheet translations.

Net income for the first quarter was $40 million or $0.48 per diluted share, compared to $58.1 million or $0.69 per diluted share in the prior-year period and net income of $70.7 million or $0.84 per diluted share in the fourth quarter of 2014.

During Q1, Syntel spent $4.4 million in CAPEX, largely in support of campus infrastructure, and finished the quarter with cash and short-term investments of $867 million. The Company ended the quarter with 24,534 employees globally.

Operational Highlights

"While the first quarter is typically a seasonally weaker period for us, this Q1 got off to a slower start than usual as some of the projects we are engaged on were slow to ramp," said Syntel CEO and President Nitin Rakesh. "We are maintaining our 2015 outlook for EPS and the lower end of our revenue range as the broader environment remains favorable and our pipelines continue to build. We are optimistic that current market conditions support a continuation of the discretionary spending trends seen last year."

"This quarter's performance is not characteristic of Syntel and we have taken actions to ensure that we stay on the growth path we have embarked on," said Rakesh. "One of the quarter's highlights is that business activity in our Healthcare and Life Sciences industry group continued to improve from second-half 2014 as we expanded our services offerings in this industry to further strengthen our market position."

"We remain committed to distinguishing our service delivery with innovative IP and a customer focus that has fortified existing relationships while presenting multiple opportunities to build new ones in our chosen domains. This commitment has helped us assemble a long-term track record of strong execution, and we look forward to building on this in the future."

2015 Guidance

Based on current visibility levels and an exchange rate assumption of 62 Indian rupees to the dollar, the Company currently expects 2015 revenue of $985 million to $1,015 million and EPS in the range of $2.70 to $2.95.

Syntel to Host Conference Call

Syntel will discuss its first quarter 2015 results today on a conference call at 10:00 a.m. (EDT). To listen to the call, please dial (877) 837-3915 in the US/Canada or (973) 638-3495 internationally. The call will also be broadcast live via the Internet at Syntel's web site: investor.syntelinc.com . Please access the site at least 15 minutes prior to the call to register and download any necessary software. A replay will be available until April 30, 2015 by dialing (855) 859-2056 and entering "27576350." International callers may dial (404) 537-3406 and enter the same passcode.

About Syntel

Syntel (Nasdaq: SYNT ) is a global provider of digital transformation, information technology and knowledge process services to Global 2000 companies. Syntel's mission is to create new opportunities for clients by harnessing our passion, talent and innovation. We combine technology expertise, industry knowledge and a global delivery model to drive business value creation. Syntel's "Customer for Life" philosophy drives our relentless focus to build long-term, collaborative client partnerships. To learn more, visit us at: www.syntelinc.com .

Safe Harbor Provision

This news release may include forward-looking statements, including those with respect to the future level of business for Syntel, Inc. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2014, or from other factors not currently anticipated. 

SYNTEL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(UNAUDITED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
 
  THREE MONTHS ENDED
  MARCH 31,
  2015 2014
     
Net revenues  $ 220,599  $ 219,523
Cost of revenues 141,785 123,500
Gross profit 78,814 96,023
Selling, general and administrative expenses 35,382 32,221
     
Income from operations 43,432 63,802
     
Other income , net 9,338 11,785
     
Income before provision for income taxes  52,770  75,587
     
Income tax expense 12,749 17,439
     
Net income  $ 40,021  $ 58,148
     
Other Comprehensive Income     
     
Foreign currency translation adjustments  $ 10,626  $ 24,847
Gains on derivatives:    
 Gains arising during period on net investment hedges  --   724
     
Unrealized gains on securities:    
 Unrealized holding gains arising during period  3,440  2,724
 Reclassification adjustment for gains included in net income  (1,868)  (1,855)
   1,572  869
     
Defined benefit pension plans:    
 Net Profit arising during period  --   -- 
 Amortization of prior service cost included in net periodic pension cost  25  2
   25  2
     
Other comprehensive income, before tax  12,223  26,442
Income tax expenses related to Other Comprehensive Income   (486)  (252)
Other comprehensive income, net of tax  11,737  26,190
     
Comprehensive Income   $ 51,758  $ 84,338
     
Dividend per share  $ --   $ -- 
     
EARNINGS PER SHARE:    
Basic  $ 0.48  $ 0.69
Diluted  $ 0.48  $ 0.69
     
Weighted average common shares outstanding:    
     
Basic 83,907 83,680
Diluted 84,127 83,944
     
SYNTEL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)
  (Unaudited)  
  March 31, December 31,
   2015   2014 
     
ASSETS    
     
Current assets:    
Cash and cash equivalents  $ 281,784  $ 197,708
Short term investments 585,168 669,353
Accounts receivable, net of allowance for doubtful accounts of $703 at March 31, 2015 and December 31, 2014, respectively 114,995 111,993
Revenue earned in excess of billings 40,654 27,493
Deferred income taxes and other current assets 65,190 56,930
Total current assets  1,087,791  1,063,477
     
Property and equipment 217,320 210,206
Less accumulated depreciation and amortization 106,157 101,155
Property and equipment, net  111,163  109,051
     
Goodwill 906 906
     
Non current Term Deposits with Banks 82 105
     
Deferred income taxes and other non current assets 61,872 50,476
     
TOTAL ASSETS $ 1,261,814 $ 1,224,015
     
LIABILITIES AND SHAREHOLDERS' EQUITY    
LIABILITIES    
Current liabilities:    
Accrued payroll and related costs  $ 48,336  $ 60,765
Income taxes payable 21,562 23,781
Accounts payable and other current liabilities 35,097 33,573
Deferred revenue 2,294 3,266
Loans and borrowings  6,968  8,852
     
Total current liabilities  114,257  130,237
     
Other non current liabilities 16,430 16,198
Non Current loans and borrowings 129,750 129,750
     
TOTAL LIABILITIES  260,437  276,185
     
SHAREHOLDERS' EQUITY    
     
Total shareholders' equity  1,001,377  947,830
     
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY  $ 1,261,814  $ 1,224,015

North America/Europe: Jon Luebke, Syntel, 248/619-3503, Asia/Pacific: Sikta Samantaray, +91 9167512186,

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 311

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 150

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 105

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 354

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 35

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

VIQ Solutions' Leadership Transition Marks New Era Ahead

Updated Category News Views 244

VIQ Solutions Marks a New Chapter with Leadership Changes VIQ Solutions Inc. is making noteworthy changes in its executive team that will undoubtedly shape the organization's path forward. The firm, known for being a global provider of AI-driven, secure digital voice and video capture technology, has announced the retirement of Susan Sumner, who has been a pivotal figure...

Continue Reading
Lucid Group's Fourth Quarter Success: Record Deliveries Ahead

Updated Category News Views 130

Lucid Group Inc Reports Strong Q4 Earnings Lucid Group Inc (NASDAQ: LCID) has revealed its fourth-quarter financial results, demonstrating a significant improvement in revenue and production metrics. The results were reported after the market closed on a recent Tuesday, showcasing the company's ongoing commitment to innovation in the electric vehicle sector. Revenue...

Continue Reading
Verily Sightline Collaborates with Bangor University in Europe

Updated Category News Views 149

Verily Partners with Bangor University for Wastewater Testing Verily, recognized for its precision health technology, is extending its wastewater surveillance program into Europe through a promising partnership with Bangor University. This collaboration aims to take advantage of the innovative wastewater-based public health programs at Bangor to enhance testing...

Continue Reading
Amaero's Strategic Supply Agreement Boosts U.S. Titanium Production

Updated Category News Views 213

Amaero Secures Strategic Long-Term Supply Agreement Significant Milestone in Domestic Supply Chain Development Amaero International Limited (ASX:3DA), a prominent U.S. manufacturer of high-quality titanium powders, has successfully signed a three-year Supply Agreement with The Perryman Company, a leader in titanium production. This agreement marks a pivotal moment in...

Continue Reading
NextPlat: Insights from Interim CEO on Future Directions

Updated Category News Views 132

NextPlat Corp's Interim CEO Update NextPlat Corp (NASDAQ: NXPL), a prominent player in the consumer products and services sector, recently issued a pivotal update from its interim CEO, David Phipps. This detailed letter serves as a roadmap to navigate the company’s future after the unexpected passing of its former CEO, Charles M. Fernandez. The focus is on leveraging...

Continue Reading